Prospective angioscopic Observation of vascular wall Re-intimal Coverage over DES IN the Infra-inguinal lesion

Prospective angioscopic Observation of vascular wall Re-intimal Coverage over DES IN the Infra-inguinal lesion - PORCINII trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018862

Enrollment

Registered

2015-08-31

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) PAD patients undergoing DES(Zilver PTX) inplantation at SFA or PA 2) DES inplantation site can be applyed angioscopic analyse. 3) Patients who can take both of aspirin and clopidogrel. 4) Patients who have provided informed consent written by themselves.

Exclusion criteria

Exclusion criteria: 1) Patients who had prior stenting, or subject limb need DES and BMS at once. 2) Paients who need other blood thinner besides aspirin and clopidogrel. 3) Patients who participate in clinical trials(besides PhIV). 4) Female patient during pregnancyor breast-feeding. 5) Patients who need hemodialysis. 6) Patients judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

Measure	Time frame
Neoitimal coverage and intra-stent thrombi by angioscopic analysis.	—

Countries

Japan

Contacts

Public ContactOsamu Iida

Kansai Rosai Hospital Cardiovascular Medicine

iida.osa@gmail.com06-6416-1221

Outcome results